176 related articles for article (PubMed ID: 33556240)
1. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
DeCarlo A; Malardier-Jugroot C; Szewczuk MR
Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis.
Sambi M; DeCarlo A; Malardier-Jugroot C; Szewczuk MR
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683806
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform.
Li X; Szewczuk MR; Malardier-Jugroot C
Drug Des Devel Ther; 2016; 10():4101-4110. PubMed ID: 28008233
[TBL] [Abstract][Full Text] [Related]
4. Functionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner Core.
Li X; Sambi M; DeCarlo A; Burov SV; Akasov R; Markvicheva E; Malardier-Jugroot C; Szewczuk MR
Nanomaterials (Basel); 2018 Aug; 8(8):. PubMed ID: 30072655
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
[TBL] [Abstract][Full Text] [Related]
7. Poly(l-lysine)-graft-folic acid-coupled poly(2-methyl-2-oxazoline) (PLL-g-PMOXA-c-FA): a bioactive copolymer for specific targeting to folate receptor-positive cancer cells.
Chen Y; Cao W; Zhou J; Pidhatika B; Xiong B; Huang L; Tian Q; Shu Y; Wen W; Hsing IM; Wu H
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2919-30. PubMed ID: 25581478
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
9. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
10. Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy.
Omurtag Ozgen PS; Atasoy S; Zengin Kurt B; Durmus Z; Yigit G; Dag A
J Mater Chem B; 2020 Apr; 8(15):3123-3137. PubMed ID: 32211704
[TBL] [Abstract][Full Text] [Related]
11. Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway.
Liu Z; Jin X; Pi W; Liu S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29070520
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the value of competition assays in folate receptor-mediated drug delivery.
Jones SK; Sarkar A; Feldmann DP; Hoffmann P; Merkel OM
Biomaterials; 2017 Sep; 138():35-45. PubMed ID: 28551461
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of folic acid functionalized terbium-doped dendritic fibrous nano-silica and Interaction with HEK 293 normal, MDA breast cancer and HT 29 colon cancer cells.
Azizi S; Soleymani J; Shadjou N
J Mol Recognit; 2020 Nov; 33(11):e2871. PubMed ID: 32677119
[TBL] [Abstract][Full Text] [Related]
14. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
15. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
[TBL] [Abstract][Full Text] [Related]
16. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522
[TBL] [Abstract][Full Text] [Related]
17. Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.
Kamen BA; Smith AK
Cancer Chemother Pharmacol; 2012 Jul; 70(1):113-20. PubMed ID: 22644798
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a pH responsive folic acid functionalized polymeric drug delivery system.
Li X; McTaggart M; Malardier-Jugroot C
Biophys Chem; 2016; 214-215():17-26. PubMed ID: 27183249
[TBL] [Abstract][Full Text] [Related]
19. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Hijaz M; Das S; Mert I; Gupta A; Al-Wahab Z; Tebbe C; Dar S; Chhina J; Giri S; Munkarah A; Seal S; Rattan R
BMC Cancer; 2016 Mar; 16():220. PubMed ID: 26979107
[TBL] [Abstract][Full Text] [Related]
20. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]